Authority: IC
35-48-3-1
Affected: IC
35-48-2-8
Sec. 4.
(a) Schedule
III shall consist of the drugs and other substances, by whatever official name,
common or usual name, chemical name, or brand name designated listed in this
section. Each drug or substance has been assigned the Controlled Substances
Code Number set forth opposite it.
(b) Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or preparation
that contains any quantity of the following substances having a stimulant
effect on the central nervous system, including its salts, isomers (whether
optical, position, or geometric), and salts of such isomers whenever the
existence of such salts, isomers, and salts of isomers is possible within the
specific chemical designation:
|
(1) Those compounds, mixtures, or preparations in
dosage unit form containing any stimulant substances listed in Schedule II,
which compounds, mixtures, or preparations were listed on August 25, 1971, as
excepted compounds under 1308.32, and any other drug of the quantitative
composition shown in that list for those drugs or that is the same, except that
it contains a lesser quantity of controlled substances
..................................................
|
. 1405
|
|
(2) Benzphetamine
..........................................................................
|
1228
|
|
(3) Chlorphentermine
........................................................................
|
1645
|
|
(4) Clortermine
.............................................................................
|
1647
|
|
(5) Mazindol
...............................................................................
|
1605
|
|
(6) Phendimetrazine
.........................................................................
|
1615
|
(c)
Unless specifically excepted or unless listed in another schedule, any
material, compound, mixture, or preparation that contains any quantity of the
following substances having a depressant effect on the central nervous system:
(1) Any compound, mixture, or preparation
containing:
|
(A) Amobarbital
........................................................................
|
2125
|
|
(B) Secobarbital
.........................................................................
|
2315
|
|
(C) Pentobarbital
........................................................................
|
2270
|
or any salt thereof and one (1) or more other active
medicinal ingredient that are not listed in any schedule.
(2) Any suppository dosage form containing:
|
(A) Amobarbital
........................................................................
|
2125
|
|
(B) Secobarbital
.........................................................................
|
2315
|
|
(C) Pentobarbital
........................................................................
|
2270
|
or any salt of any of these drugs and approved by the Food
and Drug Administration for marketing only as a suppository.
|
(3) Any substance that contains any quantity of a
derivative of barbituric acid or any salt thereof ..............
|
2100
|
|
(4) Chlorhexadol
.............................................................................
|
2510
|
|
(5) Ketamine, its salts, isomers, and salts of
isomers .................................................
Some other names for ketamine: (-2(2-chlorophenyl)
-2- (methylamino) - cyclohexanone
|
7285
|
|
(6) Lysergic acid
.............................................................................
|
7300
|
|
(7) Lysergic acid amide
........................................................................
|
7310
|
|
(8) Methyprylon
.............................................................................
|
2575
|
|
(9) Sulfondiethylmethane
......................................................................
|
2600
|
|
(10) Sulfonethylmethane
.......................................................................
|
2605
|
|
(11) Sulfonmethane
...........................................................................
|
2610
|
|
(d) Nalorphine (a narcotic drug)
.................................................................
|
9400
|
(e) Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or preparation
containing limited quantities of any of the following narcotic drugs, or any
salts thereof:
(1) Not more than one and
eight-tenths (1.8) grams of codeine, per one hundred (100) milliliters or not
more than ninety (90) milligrams per dosage unit, with an equal or greater
quantity of an isoquinoline alkaloid of opium ......... 9803
(2) Not more than one and eight-tenths (1.8)
grams of codeine, per one hundred (100) milliliters or not more than ninety
(90) milligrams per dosage unit, with one (1) or more active, nonnarcotic
ingredients in recognized therapeutic amo9u8n0ts4
(3) Not more than three hundred (300)
milligrams of dihydrocodeinone, per one hundred (100) milliliters or not more
than fifteen (15) milligrams per dosage unit, with a fourfold or greater
quantity of an isoquinoline alkaloid of opium. . . 9805
(4) Not more than three hundred (300)
milligrams of dihydrocodeinone, per one hundred (100) milliliters or not more
than fifteen (15) milligrams per dosage unit, with one (1) or more active,
nonnarcotic ingredients, in recognized therapeutic amounts
....................................................................................
9806
(5) Not more than one and
eight-tenths (1.8) grams of dihydrocodeine, per one hundred (100) milliliters
or not more than ninety (90) milligrams per dosage unit, with one (1) or more
active, nonnarcotic ingredients in recognized therapeutic
amounts....................................................................................9807
(6) Not more than three hundred (300)
milligrams of ethylmorphine, per one hundred (100) milliliters or not more than
fifteen (15) milligrams per dosage unit, with one (1) or more active,
nonnarcotic ingredients in recognized therapeutic
amounts....................................................................................9808
(7) Not more than five hundred (500)
milligrams of opium per one hundred (100) milliliters or per one hundred (100)
grams or not more than twenty-five (25) milligrams per dosage unit, with one
(1) or more active, nonnarcotic ingredients in recognized therapeutic
amounts.................................................................9809
(8) Not more than fifty (50) milligrams of
morphine, per one hundred (100) milliliters or per one hundred (100) grams with
one (1) or more active, nonnarcotic ingredients in recognized therapeutic
amounts..........................9810
(f) Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or preparation
containing any quantity of anabolic steroids, including its salts, isomers, and
salts of isomers whenever the existence of such salts of isomers is possible
within the specific chemical
designation................................................4000
(g) For hallucinogenic substances, dronabinol
(synthetic) in sesame oil and encapsulated in a Zsoft gelatin capsule in a
United States Food and Drug Administration-approved drug
product.................................................7369
(Some other names for dronabinol: (6aR-trans) - 6a, 7, 8, 10a
- tetrahydro-6,6,9 - trimethyl - 3-pentyl- 6H - dibenzo[b,d]pyrano-1-ol, or (1)
[ALPHA]9 - (trans) -
tetrahydrocan-nabinol.)
Notes
856 IAC 2-2-4
Indiana Board of
Pharmacy; Reg 28, Ch II, Sec 2.13; filed Jul 9, 1974, 9:29 a.m.: Unpublished;
filed Jun 9, 1977, 8:55 a.m.: Unpublished; filed May 26, 2000, 8:52 a.m.: 23 IR
2503; readopted filed Nov 14, 2001, 2:45 p.m.: 25 IR 1341; readopted filed Oct
4, 2007, 3:33 p.m.: 20071031-IR-856070060RFA; readopted filed November 25,
2013, 9:24 a.m.: 20131225-IR-856130308RFA
Readopted filed 2/15/2024, 1:16 p.m.:
20240313-IR-856230795RFA
